Anti-Viral Compounds

Compounds effective in inhibiting replication of Hepatitis C virus ("HCV") or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes...

Full description

Saved in:
Bibliographic Details
Main Authors SHANLEY JASON P, WAGNER ROLF, BETEBENNER DAVID A, ROCKWAY TODD W, CARRICK ROBERT J, LU LIANGJUN, HE WENPING, COOPER CURT S, TUFANO MICHAEL D, MOLLA AKHTERUZZAMAN, MADIGAN DAROLD L, KRUEGER ALLAN C, MOTTER CHRISTOPHER E, MASSE SHERIE V.L, MO HONGMEI, ANDERSON DAVID D, PILOT-MATIAS TAMI J, IWASAKI NOBUHIKO, KEMPF DALE J, ZHANG RONG
Format Patent
LanguageEnglish
Published 07.10.2010
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Compounds effective in inhibiting replication of Hepatitis C virus ("HCV") or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.
Bibliography:Application Number: US20100817808